Truway Health, Inc.
TH-CLINICAL-TIME is a prospective, longitudinal observational study evaluating how changes in clinical measurements over time may help researchers better understand patient health trajectories and clinically meaningful outcomes. The study will examine patterns such as changes from an individual's baseline, rate of change, persistence of abnormalities, variability, recurrence, and recovery following clinical events. Data may include routinely collected clinical measurements, physiologic observations, laboratory results, cardiac measurements, imaging-derived measurements, patient-reported information, and remote or digital health data when available and permitted by the study protocol. The study will investigate whether these temporal patterns provide additional information beyond individual measurements taken at a single point in time. The planned study horizon extends from 2026 through 2076, while individual participant follow-up will occur according to the approved study schedule, consent, and applicable requirements.
TH-CLINICAL-TIME is a prospective longitudinal observational research study designed to investigate the role of temporal dynamics in clinical medicine. The fundamental premise is that a clinical measurement may have different significance depending on its relationship to a patient's prior measurements, the direction and rate of change, the duration of an observed abnormality, the sequence of preceding or subsequent observations, and the patient's subsequent recovery or deterioration. The study will establish longitudinal research datasets that permit evaluation of individual and population-le…
Inclusion Criteria: * Adults aged 18 years or older. * Able and willing to provide informed consent, when informed consent is required by the approved study protocol and applicable regulations. * Willing and able to participate in longitudinal collection or evaluation of clinical, physiologic, laboratory, imaging-derived, patient-reported, or remote/digital health information as applicable to the study protocol. * Ability to complete the protocol-defined follow-up schedule or provide sufficient longitudinal observations for analysis. * Individuals with or without established medical condition…
This is a prospective observational study with no protocol-assigned drug, biologic, device, behavioral intervention, or other therapeutic intervention. Participants receive clinical care according to usual practice and applicable clinical decisions. The study observes and analyzes longitudinal clinical and physiologic data to characterize temporal dynamics and their association with clinically meaningful outcomes. Data collection may include routinely available clinical measurements, laboratory results, imaging-derived measurements, patient-reported information, and remote or digital health measurements when permitted by the protocol.